Tag Archives: Patent Reform

CNBC Commentary: Hedge funds, ‘reverse trolls’ crushing biopharma innovation

Vote No on HR 9

Patents are the lifeblood of medical innovation. They are the cornerstone that enables companies to perform the long and costly research and development for cures and therapies to combat devastating diseases such as cancer, HIV and Alzheimer’s. Unfortunately, the system that helps protect these innovations is being abused by outside interests. BIO and others have called upon Congress to fix these problems as part of a greater patent reform debate. Today one more voice joined Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,

This Independence Day, Let’s Thank the Inventors

American flag

Happy Birthday AMERICA! That’s right, this Saturday is July 4. And yes, that means what you think it means. Prepare yourself for Facebook posts of your old college roommate in an American flag t-shirt, Instagrams from your sister who makes the world’s GREATEST potato salad and texts from your cousin about prime firework viewing in D.C. (Hint: Avoid the crowds and head to the Marine Corps War Memorial and Netherlands Carillion in Rosslyn – you Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , ,

IP Sessions at BIO 2015: The Impact of the Inter Partes Review on (BIO)Pharma

patent

The Intellectual Property Track at the BIO International Convention was a chance for IP thought leaders in the biotech sector to discuss some of the most pressing issues impacting the industry. Let’s recap what we learned from one of the IP sessions at BIO 2015: The Impact of IPRs on (BIO)Pharma On Tuesday, patent litigation experts met to discuss inter partes review proceedings and how they are impacting biotechnology. Panelists from The Impact of IPRs Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , , , , , ,

Sen Menendez Asks SEC to Investigate IPR Abuses

Securities and Exchange Commission

New Jersey Senator Bob Menendez has asked the Securities and Exchange Commissioner (SEC) to investigate a new investment scheme designed to manipulate the stock prices of companies engaged in research and development of innovative medical therapies, to determine if the practice is illegal. As reported in this Bloomberg Business article, certain investment firms are shorting the stocks of patent-dependent life sciences companies and then using new patent litigation procedures to challenge their patents and drive Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

11 Days Until BIO 2015: IP Networking and Meetup Opportunities

BIO Convention Networking

This year’s BIO International Convention is fast approaching, with plenty of opportunities for the best and brightest in the biotech IP sector to meet and discuss the most pressing issues affecting the industry today. Here are some of the receptions, networking, and meet-up opportunities for the Intellectual Property Track at this year’s convention: Monday: Kickoff Concert (Open to Convention Access registrants and higher) 6:30 p.m.-9:30 p.m. Liacouras Center Philadelphia is home to a rich musical Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,